Brookfield Corp’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-78,450
Closed -$2.05M 429
2023
Q2
$2.05M Buy
78,450
+33,478
+74% +$884K 0.01% 404
2023
Q1
$1.24M Sell
44,972
-81,423
-64% -$2.15M ﹤0.01% 479
2022
Q4
$2.87M Buy
126,395
+22,531
+22% +$627K 0.01% 345
2022
Q3
$3.54M Sell
103,864
-1,118
-1% -$41.3K 0.01% 335
2022
Q2
$3.06M Sell
104,982
-17,216
-14% -$438K 0.01% 333
2022
Q1
$3.27M Sell
122,198
-13,402
-10% -$316K 0.01% 328
2021
Q4
$3.51M Buy
+135,600
New +$3.38M 0.01% 264

Other funds holding PRVA

Brookfield Corp's PRVA Position: Q3 2023 in Review

Brookfield Corp sold out of Privia Health (PRVA) in Q3 2023, closing a stake of 78,450 shares — an estimated $2.05M sold.

Brookfield Corp first reported a position in PRVA in Q4 2021 and held it in 7 quarters. The position peaked at $3.54M in Q3 2022. 217 funds tracked by Wall St. Rank hold PRVA as of Q3 2023.

  • Brookfield Corp reported no remaining Privia Health position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 78,450 Privia Health shares in Q3 2023, an estimated $2.05M.
  • Brookfield Corp first reported a position in Privia Health in Q4 2021 and held it in 7 quarters.
  • Brookfield Corp's Privia Health position peaked at $3.54M in Q3 2022.
  • 217 funds tracked by Wall St. Rank held Privia Health as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.